MorphoSys AG (MOR): Operatsion rentabellik

MorphoSys Corporation (MOR) - korporativ logo

Geopolitik keskinliklar va sanksiyalar komponentlar logistikasini murakkablashtirib, MorphoSys AG uchun yangi dori vositalarining ro'yxatdan o'tishini sekinlashtirmoqda. Yillik operatsion marja ushbu qiyinchiliklarni aks ettiradi, bunda -219.10 ushbu parametrning miqdorini ko'rsatadi. Biroq, Shveytsariya sog'liqni saqlash giganti tomonidan sotib olinishi mielofibroz terapiyasining tarqalishini kengaytiradi, limfoma davolash uchun patentlangan antitelalardan tushadigan barqaror royalti to'lovlari esa biznesning moliyaviy barqarorligini ta'minlaydi.

MOR - MorphoSys Sotuvning operatsion rentabelligi 04.07.2022 - 10.08.2024 oraligʻida

MorphoSys AG - tahliliy kesimlar va asosiy koʻrsatkichlar (MOR)

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning asosiy tahlili:MorphoSys Inc, MOR
MorphoSys Corporation brendining mahsuloti

MorphoSys AG uchun operatsion marja qarz yuklamasi va soliqlarning ta'sirini hisobga olmagan holda, global hamkorlardan olinadigan royalti orqali antitelolarni monetizatsiya qilish samaradorligini aks ettiradi. Operatsion marjani tahlil qilish asosiy biznes tomonidan yaratilgan foyda ulushini baholash imkonini beradi, bunda ushbu ko'rsatkichning barqaror o'sishi ilmiy modelning kengaytiriluvchanligini va kompaniyaning pul oqimlari barqarorligini tasdiqlaydi.

MorphoSys AG (MOR) raqobatchilari

Operatsion rentabellik BeiGene Ltd|Halozyme Therapeutics - Operatsion foyda marjasi|Sotuvning operatsion marjasi RVMD (Revolution Medicines Corp)|Operatsion foyda koeffitsiyenti AAPG|Operatsion rentabellik CG Oncology Therapeutics CGON|Operatsion foyda normasi URGN|BCAX: Sotuvning operatsion marjasi|PSNL: Operatsion rentabellik|Erasca (ERAS) - Operatsion rentabellik|DCTH - Operatsion faoliyat rentabelligi|YMAB (Y-mAbs Corp) - Operatsion marja|Sotuvning operatsion marjasi Aura Biosciences (AURA)|Operatsion rentabellik Candel Therapeutics Inc. (CADL)|Sotuvning operatsion marjasi Accuray, Inc. ARAY|Operatsion rentabellik sellaslifesciences.com SLS|Operatsion foyda normasi ACTU|CTOR - Operatsion rentabellik|Operatsion faoliyat rentabelligi tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Operatsion rentabellik|FATE: Operatsion foyda koeffitsiyenti|WHWK (Aadi Bioscience, Inc.) - Operatsion marja|TCRX (TScan Therapeutics) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Champions Oncology (CSBR)|Operatsion faoliyat rentabelligi XBiotech USA|Operatsion rentabellik CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Sotuvning operatsion rentabelligi|RADX - Operatsion rentabellik|ARTV - Operatsion marja|Adlai Nortye Ltd (ANL) - Operatsion rentabellik|Veru Pharma - Operatsion foyda normasi|Operatsion rentabellik Tempest Therapeutics Corp|Operatsion foyda bo'yicha sotuv rentabelligi XLO (Xilio Therapeutics, Inc.)|Operatsion marja RENB|MURA (Mural Oncology) - Operatsion foyda normasi|Operatsion marja KAPA (Kairos Pharma Ltd)|OKUR: Operatsion foyda bo'yicha sotuv rentabelligi|GDTC: Sotuvning operatsion marjasi|CRIS - Operatsion marja|APLM: Operatsion marja|Sotuvning operatsion rentabelligi tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Operatsion marja|Operatsion marja Genprex Inc.|Operatsion marja CLDI|Sotuvning operatsion marjasi Sunshine Biopharma, Inc. SBFM|Operatsion marja XBIO (Xenetic Biosciences)|Operatsion foyda normasi SLRX|PPBT - Operatsion rentabellik|AONC (aoncology.com) - Operatsion foyda bo'yicha sotuv rentabelligi|BGNE: Operatsion marja|Checkpoint Therapeutics Inc (CKPT) - Operatsion marja|ELEV (Elevation Oncology Inc.) - Operatsion marja|icadmed.com (ICAD) - Operatsion faoliyat rentabelligi|Operatsion marja IKNA|NTBL (Notable Labs) - Operatsion foyda normasi|Operatsion marja VIRX (Viracta Therapeutics)|NAYA: Operatsion foyda bo'yicha sotuv rentabelligi|Ascentage Pharma Group International - Operatsion marja